|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/08 | (2006.01) |
| A61K 8/64 | (2006.01) | ||
| A61Q 19/08 | (2006.01) |
| (11) | Number of the document | 2379104 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09837072.9 |
| Date of filing the European patent application | 2009-12-28 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation | 2018-04-10 |
| (86) | Number | PCT/US2009/069576 |
| Date | 2009-12-28 |
| (87) | Number | WO 2010/078242 |
| Date | 2010-07-08 |
| (30) | Number | Date | Country code |
| 142063 P | 2008-12-31 | US |
| (72) |
RUEGG, Curtis, L., US
STONE, Hongran, F., US
WAUGH, Jacob, M., US
|
| (73) |
Revance Therapeutics, Inc.,
7555 Gateway Boulevard, Newark, CA 94560,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Injekcinės botulino toksino vaisto formos |
| INJECTABLE BOTULINUM TOXIN FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2020-11-26 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-12-28 |